Delivery Order SPE2DB25D3404-SPE2DB25FUPYJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lyrica 100 mg capsules in quantities of 90 units, with a ceiling value of $6,189.51. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is scheduled for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lyrica 100 mg capsules (90-count units) at a ceiling value of $1,260.77. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for ultimate completion by August 1, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lyrica 100 mg capsules (90 count) with a contract value of $4,272.77. This is a firm fixed price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside award. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Lyrica 300 mg capsules (90-count). The contract carries a ceiling value of $1,179.94 under firm fixed pricing terms, with an ultimate completion date of July 25, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a child contract issued under a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,100.28 for Lyrica 300 mg capsules (90-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (90-count units) under a firm fixed price contract with a ceiling value of $1,183.60. The order was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lyrica 100 mg capsules. The contract has a ceiling value of $1,647.67 and a period of performance through April 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.94 to AmerisourceBergen Drug Corp for 90-count bottles of Lyrica 300 mg capsules. This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Lyrica 200 mg capsules (90-count units) under a firm fixed price contract with a ceiling value of $1,775.64. The order is scheduled for completion by August 25, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $4,746.84 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPYJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (unit dose, 100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with a ceiling value of $1,128.56 and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and the place of performance for this contract. This delivery order falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs. Lyrica, a neurological treatment medication, aligns with the therapeutic diversity covered under the prime contract, which encompasses specialty medications, brand-name and generic drugs, and other critical medical commodities for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/20/25 |